Whether you’re a newbie who just watched The Wolf of Wall Street or you’re a seasoned trader whose previous fliers on penny stocks have burned one too many holes in your pocket, the story is the same — stay away from penny stocks.
Penny stocks (classified by the SEC as anything trading under $5) are among the more volatile securities you’ll ever come across. There are a few reasons for that, not the least of which is that their low prices confuse many would-be investors. Remember, just because it trades for a dollar doesn’t mean that it’s a cheap stock.
Consider Lifeway Foods (NASDAQ:LWAY), which trades for a mere $3.60. Compare that to Danone (OTCMKTS:DANOY), trading at $15.46. Lifeway certainly appears cheaper, but with a price-to-earnings (P/E) ratio of 57 versus Danone’s P/E of 15, you’re actually paying a premium for LWAY stock.
That tiny price tag also makes penny stocks more susceptible to scammers and wild swings in price. All of this is not to say that buying penny stocks can’t go your way, but the odds are stacked against you.
Top 5 Low Price Stocks To Invest In 2019: Karyopharm Therapeutics Inc.(KPTI)
Advisors' Opinion:- [By Joseph Griffin]
Karyopharm Therapeutics Inc (NASDAQ:KPTI) major shareholder Ltd Chione sold 80,876 shares of the stock in a transaction that occurred on Thursday, August 9th. The stock was sold at an average price of $18.52, for a total value of $1,497,823.52. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.
- [By Stephan Byrd]
Karyopharm Therapeutics (NASDAQ:KPTI) last issued its quarterly earnings data on Thursday, March 15th. The company reported ($0.80) EPS for the quarter, missing the consensus estimate of ($0.66) by ($0.14). The business had revenue of $1.53 million during the quarter, compared to the consensus estimate of $2.26 million. During the same quarter in the prior year, the firm posted ($0.65) earnings per share. The company’s revenue for the quarter was up 3163.8% compared to the same quarter last year. analysts anticipate that Karyopharm Therapeutics will post -2.82 earnings per share for the current fiscal year.
- [By Stephan Byrd]
Karyopharm Therapeutics (NASDAQ:KPTI) – Investment analysts at Jefferies Group lowered their Q2 2018 earnings estimates for Karyopharm Therapeutics in a research note issued on Tuesday, May 15th. Jefferies Group analyst M. Raycroft now forecasts that the company will post earnings per share of ($0.77) for the quarter, down from their prior estimate of ($0.62). Jefferies Group has a “Buy” rating on the stock. Jefferies Group also issued estimates for Karyopharm Therapeutics’ Q3 2018 earnings at ($0.71) EPS, Q4 2018 earnings at ($0.78) EPS, FY2018 earnings at ($3.03) EPS, FY2019 earnings at ($2.66) EPS, FY2020 earnings at ($1.05) EPS, FY2021 earnings at ($0.74) EPS and FY2022 earnings at $0.73 EPS.
- [By Joseph Griffin]
Karyopharm Therapeutics Inc (NASDAQ:KPTI) EVP Christopher Brett Primiano sold 10,000 shares of the stock in a transaction that occurred on Monday, September 10th. The shares were sold at an average price of $18.90, for a total value of $189,000.00. Following the transaction, the executive vice president now directly owns 7,881 shares of the company’s stock, valued at $148,950.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
- [By Ethan Ryder]
Karyopharm Therapeutics Inc (NASDAQ:KPTI) major shareholder Ltd Chione sold 251,468 shares of the business’s stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $20.94, for a total transaction of $5,265,739.92. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
Top 5 Low Price Stocks To Invest In 2019: CIRCOR International, Inc.(CIR)
Advisors' Opinion:- [By Stephan Byrd]
Get a free copy of the Zacks research report on CIRCOR International (CIR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Shane Hupp]
Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:
Get CIRCOR International alerts: CIRCOR International, Inc. Forecasted to Earn Q2 2018 Earnings of $0.50 Per Share (CIR) (americanbankingnews.com) CIRCOR Mexico Earns API Certifications for Quality Management (finance.yahoo.com) SunTrust Banks Research Analysts Boost Earnings Estimates for CIRCOR International, Inc. (CIR) (americanbankingnews.com) CIRCOR International (CIR) Lowered to Strong Sell at ValuEngine (americanbankingnews.com) CIRCOR International (CIR) Rating Lowered to Hold at Zacks Investment Research (americanbankingnews.com)A number of research firms have issued reports on CIR. ValuEngine downgraded CIRCOR International from a “sell” rating to a “strong sell” rating in a report on Wednesday, May 2nd. Zacks Investment Research upgraded CIRCOR International from a “sell” rating to a “buy” rating and set a $47.00 price target for the company in a report on Tuesday, May 1st. SunTrust Banks restated a “buy” rating and set a $56.00 price target on shares of CIRCOR International in a report on Friday, March 2nd. Finally, Stifel Nicolaus restated a “buy” rating and set a $54.00 price target (down from $61.00) on shares of CIRCOR International in a report on Thursday, March 1st. Three analysts have rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $57.50.
- [By Max Byerly]
CIRCOR International (NYSE: CIR) and ARC Group WorldWide (NASDAQ:ARCW) are both small-cap industrial products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, valuation, profitability and institutional ownership.
- [By Stephan Byrd]
Peel Hunt reaffirmed their hold rating on shares of Circassia Pharmaceuticals (LON:CIR) in a report published on Thursday.
A number of other research analysts have also recently commented on the company. Numis Securities decreased their price target on Circassia Pharmaceuticals from GBX 180 ($2.42) to GBX 140 ($1.88) and set a buy rating on the stock in a research report on Tuesday, April 24th. JPMorgan Chase & Co. restated a neutral rating on shares of Circassia Pharmaceuticals in a research report on Tuesday, April 24th.
- [By Stephan Byrd]
Get a free copy of the Zacks research report on CIRCOR International (CIR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Stephan Byrd]
Get a free copy of the Zacks research report on CIRCOR International (CIR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 Low Price Stocks To Invest In 2019: The Herzfeld Caribbean Basin Fund, Inc.(CUBA)
Advisors' Opinion:- [By Stephan Byrd]
Media headlines about Herzfeld Caribbean Basin Fund, Inc. common stock (NASDAQ:CUBA) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Herzfeld Caribbean Basin Fund, Inc. common stock earned a news sentiment score of 0.00 on Accern’s scale. Accern also gave news stories about the investment management company an impact score of 48.5554072096128 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
Top 5 Low Price Stocks To Invest In 2019: County Bancorp, Inc.(ICBK)
Advisors' Opinion:- [By Logan Wallace]
County Bancorp (NASDAQ:ICBK) has received an average recommendation of “Hold” from the six research firms that are currently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $32.75.
- [By Max Byerly]
Southern National Banc. of Virginia (NASDAQ: ICBK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, institutional ownership, profitability, risk and dividends.
- [By Stephan Byrd]
County Bancorp Inc (NASDAQ:ICBK) President Timothy J. Schneider sold 1,000 shares of the stock in a transaction on Monday, June 4th. The shares were sold at an average price of $27.55, for a total value of $27,550.00. Following the completion of the sale, the president now owns 113,882 shares in the company, valued at $3,137,449.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
- [By Max Byerly]
Middlefield Banc (NASDAQ: ICBK) and County Bancorp (NASDAQ:ICBK) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings.
- [By Ethan Ryder]
Get a free copy of the Zacks research report on County Bancorp (ICBK)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 Low Price Stocks To Invest In 2019: CPI Aerostructures, Inc.(CVU)
Advisors' Opinion:- [By Ethan Ryder]
Penn Capital Management Co. Inc. lessened its holdings in shares of CPI Aero (NYSEAMERICAN:CVU) by 22.5% in the 1st quarter, Holdings Channel reports. The firm owned 253,588 shares of the aerospace company’s stock after selling 73,720 shares during the quarter. Penn Capital Management Co. Inc.’s holdings in CPI Aero were worth $2,472,000 as of its most recent filing with the SEC.
- [By Lisa Levin]
CPI Aerostructures, Inc. (NYSE: CVU) is estimated to report quarterly earnings at $0.1 per share on revenue of $18.50 million.
SORL Auto Parts, Inc. (NASDAQ: SORL) is expected to report quarterly earnings at $0.19 per share on revenue of $86.96 million.
No comments:
Post a Comment